Seminars in Thrombosis and Hemostasis

LinksSchließen

Referenz

Shapiro AD, Ragni MV, Valentino LA , et al.
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

Blood 2012;
119 (3) 666-672

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: